Literature DB >> 30244169

USF2 inhibits the transcriptional activity of Smurf1 and Smurf2 to promote breast cancer tumorigenesis.

Yawen Tan1, Yujiao Chen2, Mengge Du2, Zhiqiang Peng3, Ping Xie4.   

Abstract

Smurf1 (Smad ubiquitylation regulatory factor 1) and Smurf2 are negative regulators of the TGF-β (transforming growth factor-β) pathway. The protein stability and ubiquitin E3 activity regulation of Smurfs have been well studied. However, the mechanism of Smurfs expression at the transcriptional level remains uncharacterized. Here, we reported that USF2 (upstream stimulatory factor 2), a basic helix-loop-helix-leucine-zip transcription factor, is necessary for the transcriptional activity of Smurf1 and Smurf2. The 5'-flanking sequences of the Smurfs gene have more than one E-box motifs, and USF2 bounds the Smurfs promoter in vitro and in vivo. Over-expression USF2 inhibited the transcriptional activity of the Smurfs, and Smurfs mRNA was markedly decreased. Therefore, the activity of TGF-β was distinctly enhanced. Furthermore, in human breast cancers, USF2 was abnormally high expressed and correlated with cancer progression. USF2 was specifically inversely correlated with Smurfs in Luminal A subtype breast cancer patients. These findings suggest the mechanism regulation of Smurfs transcriptional activity, and shed new light on the cancer-promoting role of USF2.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer; Smurf; Transcriptional activity; USF2

Mesh:

Substances:

Year:  2018        PMID: 30244169     DOI: 10.1016/j.cellsig.2018.09.013

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis.

Authors:  Mengjun Ma; Wen Yang; Zhaopeng Cai; Peng Wang; Hongyu Li; Rujia Mi; Yuhang Jiang; Zhongyu Xie; Pengfei Sui; Yanfeng Wu; Huiyong Shen
Journal:  Stem Cells       Date:  2021-02-06       Impact factor: 6.277

Review 2.  TGF-β1-p53 cooperativity regulates a profibrotic genomic program in the kidney: molecular mechanisms and clinical implications.

Authors:  Craig E Higgins; Jiaqi Tang; Badar M Mian; Stephen P Higgins; Cody C Gifford; David J Conti; Kirstan K Meldrum; Rohan Samarakoon; Paul J Higgins
Journal:  FASEB J       Date:  2019-07-06       Impact factor: 5.834

3.  hsa-miR-875-5p inhibits tumorigenesis and suppresses TGF-β signalling by targeting USF2 in gastric cancer.

Authors:  Shenshuo Gao; Zhikai Zhang; Xubin Wang; Yan Ma; Chensheng Li; Hongjun Liu; Changqing Jing; Leping Li; Xiaobo Guo
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 4.  SMURF1, a promoter of tumor cell progression?

Authors:  Qin Xia; Yang Li; Da Han; Lei Dong
Journal:  Cancer Gene Ther       Date:  2020-11-17       Impact factor: 5.987

5.  Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury.

Authors:  Jing Huang; Ping Xie; Yuan Dong; Wei An
Journal:  Cell Death Differ       Date:  2020-10-27       Impact factor: 15.828

6.  The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC.

Authors:  Xiaosong Wang; Lei Xing; Rui Yang; Hang Chen; Min Wang; Rong Jiang; Luyu Zhang; Junxia Chen
Journal:  Mol Cancer       Date:  2021-06-11       Impact factor: 27.401

7.  Loss of USF2 promotes proliferation, migration and mitophagy in a redox-dependent manner.

Authors:  Tabughang Franklin Chi; Fawzi Khoder-Agha; Daniela Mennerich; Sakari Kellokumpu; IIkka Miinalainen; Thomas Kietzmann; Elitsa Y Dimova
Journal:  Redox Biol       Date:  2020-10-07       Impact factor: 11.799

8.  Aberrant expression of USF2 in refractory rheumatoid arthritis and its regulation of proinflammatory cytokines in Th17 cells.

Authors:  Dan Hu; Emily C Tjon; Karin M Andersson; Gabriela M Molica; Minh C Pham; Brian Healy; Gopal Murugaiyan; Nathalie Pochet; Vijay K Kuchroo; Maria I Bokarewa; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.